AzTrials
AzTrials

Gallbladder NeoplasmsCRGGCNCT04140552

Chinese Research Group of Gallbladder Cancer

An observational study of Gallbladder Neoplasms, run by Shanghai Jiao Tong University School of Medicine at 55 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration. Read more about this study

Who is it for?
Any age
Conditions the study is for
Gallbladder Neoplasms
How many people
10,000 participants
Where
55 sitesChina
Study dates
1 Jan 2008to 31 Dec 2025
How long will I take part?
5 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients from 2008 to 2020 diagnosed with gallbladder cancer in collaborated hospitals in China.

Who may be able to join

  • Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer).
  • Patients with accessible electronic medical record

Who cannot join

  • Patients with undetermined primary site of cancer.

Trial locations and contacts

55 sites in 1 country.

Yingbin Liu, MD, PhD contact

+8613918803900

laoniulyb@163.com

55 sites in 1 country

China55 sites, 55 recruiting

  • Baotou City Central Hospital

    Baotou, Inner Mongolia, 014040

    Mingzhang Li, MD

    Recruiting

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, 233004

    Jianguang Jia, MD

    Recruiting

  • The First Bethune Hospital of Jilin University

    Changchun, Jilin, 130021

    Yajun Geng, MD

    Recruiting

  • China-Japan Union Hospital of Jilin University

    Changchun, Jilin, 130033

    Hong Cao, MD

    Recruiting

  • The Second Hospital of Jilin University

    Changchun, Jilin, 130041

    Xuewen Zhang, MD

    Recruiting

  • People's Hospital of Hunan Province

    Changsha, Hunan, 410001

    Changjun Liu, MD

    Recruiting

  • Changshu No.1 People's Hospital

    Changshu, Jiangsu, 215500

    Jianfeng Gu, MD

    Recruiting

  • Heping Hospital Affiliated to Changzhi Medical College

    Changzhi, Shanxi, 046000

    Buqiang Wu, MD

    Recruiting

  • Changzhou No.2 People's Hospital

    Changzhou, Jiangsu, 213003

    Chunfu Zhu, MD

    Recruiting

  • The First Hospital of Lanzhou University

    Gansu, Lanzhou, 730000

    Xun Li, MD

    Recruiting

  • The Second Affiliated Hospital of Zhejiang University School of medicine

    Hangzhou, Zhejiang, 310009

    Jinhui Zhu, MD

    Recruiting

  • Sir Run Run Shaw Hospital

    Hangzhou, Zhejiang, 310020

    Defei Hong, MD

    Recruiting

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, 310022

    Xinbao Wang, MD

    Recruiting

  • The First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150009

    Bei Sun, MD

    Recruiting

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, 150081

    Bing Li, 150081

    Recruiting

  • The Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150086

    Yunfu Cui, MD

    Recruiting

  • Anhui Provincial Hospital

    Hefei, Anhui, 230001

    Lianxin Liu, MD

    Recruiting

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, 230022

    Yeben Qian, MD

    Recruiting

  • Huzhou Central Hospital

    Huzhou, Zhejiang, 313000

    Weilong Cai, MD

    Recruiting

  • The First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, 650031

    Kunhua Wang, MD

    Recruiting

  • Jiangxi Provincial People's Hospital

    Nanchang, Jiangxi, 330006

    Xiaoliang Chen, MD

    Recruiting

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330008

    Lu Fang, MD

    Recruiting

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330019

    Linhui Zheng, MD

    Recruiting

  • Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

    Nanjing, Jiangsu, 210008

    Yudong Qiu, MD

    Recruiting

  • The First People's Hospital of Nantong

    Nantong, Jiangsu, 226001

    Hong Zang, MD

    Recruiting

  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, 226021

    Peng Wang, MD

    Recruiting

  • Nantong Tumor Hospital

    Nantong, Jiangsu, 226361

    Hongyu Cai, MD

    Recruiting

  • Ningbo First Hospital

    Ningbo, Zhejiang, 315010

    Zhiping Zhang, MD

    Recruiting

  • Yinzhou Hospital Affiliated to Medical School of Ningbo University

    Ningbo, Zhejiang, 315040

    Kejun Hua, MD

    Recruiting

  • Zhongshan Hospital

    Shanghai, Shanghai Municipality, 200032

    Houbao Liu, MD

    Recruiting

  • Putuo District People's Hospital of Shanghai

    Shanghai, Shanghai Municipality, 200062

    Jiahua Yang, MD

    Recruiting

  • Shanghai General Hospital

    Shanghai, Shanghai Municipality, 200080

    Junmin Xu, MD

    Recruiting

  • Xinhua Hospital

    Shanghai, Shanghai Municipality, 200092

    Yingbin Liu, 13918803900, laoniulyb@163.com

    Recruiting

  • Eastern Hepatobiliary Surgery Hospital

    Shanghai, Shanghai Municipality, 200438

    Xiaoqing Jiang

    Recruiting

  • Central Hospital of Minhang District

    Shanghai, Shanghai Municipality, 201100

    Longhua Rao, MD

    Recruiting

  • Shanghai Pudong Hospital

    Shanghai, Shanghai Municipality, 201399

    Xiaoping Yang, MD

    Recruiting

  • Shanghai Fengxian District Central Hospital

    Shanghai, Shanghai Municipality, 201499

    Xueli Zhang, MD

    Recruiting

  • Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, 202150

    Zhewei Fei, MD

    Recruiting

  • Shaoxing People's Hospital

    Shaoxing, Zhejiang, 312000

    Feng Tao, MD

    Recruiting

  • Shaoxing Second Hospital

    Shaoxing, Zhejiang, 312000

    Zaiyang Zhang, MD

    Recruiting

  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, 110004

    Chaoliu Dai, MD

    Recruiting

  • The Second Affiliated Hospital of Suzhou University

    Suzhou, Jiangsu, 215004

    Xiaoming Ma, MD

    Recruiting

  • The First People's Hospital of Taicang

    Taicang, Jiangsu, 215400

    Yi Wang, MD

    Recruiting

  • First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, 030001

    Jiansheng Liu, MD

    Recruiting

  • Shanxi Provincial Cancer Hospital

    Taiyuan, Shanxi, 030013

    Xueyi Dang, MD

    Recruiting

  • Tianjin Medical University Cancer Hospital

    Tianjin, Tianjin Municipality, 300060

    Jihui Hao, MD

    Recruiting

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, 830054

    Wei Han, MD

    Recruiting

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, 325015

    Mengtao Zhou, MD

    Recruiting

  • Wuxi Second People's Hospital

    Wuxi, Jiangsu, 214002

    Lei Wang, MD

    Recruiting

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, 710061

    Chang Liu, MD

    Recruiting

  • Qinghai Provincial People's Hospital

    Xining, Qinghai, 810007

    Haihong Zhu, MD

    Recruiting

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, 221006

    Jian Hong, MD

    Recruiting

  • Xuzhou Central Hospital

    Xuzhou, Jiangsu, 221009

    Yuzhen Xu, MD

    Recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, 450003

    Yawei Hua, MD

    Recruiting

  • The Fifth Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, 450052

    Xiaoyong Li, MD

    Recruiting

Other trials in China

About this study

The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.

Read the detailed description

The objectives of the CRGGC are as follows:

  1. To study the current diagnosis and treatment of gallbladder cancer in China.
  2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer.
  3. To improve the accurate staging of gallbladder cancer.
  4. To standardize the treatment with gallbladder cancer.
Keywords
gallbladder neoplasms, gallbladder cancer
Medical subject headings
Gallbladder Neoplasms

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall Survival

    The overall survival data were defined by (date of death) - (date of first diagnosis). The survival status of patients were retrieved from follow-up.

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2019
  2. Study start1 Jan 2008
  3. Primary completion31 Dec 2022 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
10,000 participants (estimated)
Target duration
5 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT04140552
Sponsor's protocol ID
CRGGC_LYB_2019
Acronym
CRGGC
Status last verified
Jun 2021
First submitted
24 Oct 2019
Last updated
30 Jun 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No plan for IPD access is scheduled.

Publications

  • Li L, Ren T, Liu K, Li ML, Geng YJ, Yang Y, Li HF, Li XC, Bao RF, Shu YJ, Weng H, Gong W, Lau WY, Wu XS, Liu YB. Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit. Front Oncol. 2021 Jun 29;11:692647. doi: 10.3389/fonc.2021.692647. eCollection 2021.

    PubMed 34268122

  • Ren T, Li Y, Zhang X, Geng Y, Shao Z, Li M, Wu X, Wang XA, Liu F, Wu W, Shu Y, Bao R, Gong W, Dong P, Dang X, Liu C, Liu C, Sun B, Liu J, Wang L, Hong D, Qin R, Jiang X, Zhang X, Xu J, Jia J, Yang B, Li B, Dai C, Cao J, Cao H, Tao F, Zhang Z, Wang Y, Jin H, Cai H, Fei Z, Gu J, Han W, Feng X, Fang L, Zheng L, Zhu C, Wang K, Zhang X, Li X, Jin C, Qian Y, Cui Y, Xu Y, Wang X, Liu H, Hua Y, Liu C, Hao J, Wang C, Li Q, Li X, Liu J, Li M, Qiu Y, Wu B, Zheng J, Chen X, Zhu H, Hua K, Yan M, Wang P, Zang H, Ma X, Hong J, Liu Y. Protocol for a gallbladder cancer registry study in China: the Chinese Research Group of Gallbladder Cancer (CRGGC) study. BMJ Open. 2021 Feb 16;11(2):e038634. doi: 10.1136/bmjopen-2020-038634.

    PubMed 33593763

Questions about this trial

What is this clinical trial studying?

An observational study of Gallbladder Neoplasms, run by Shanghai Jiao Tong University School of Medicine at 55 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 55 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yingbin Liu, MD, PhD (+8613918803900, laoniulyb@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall Survival (time frame: 5 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04140552, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2021.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in